$-0.13
(Market cap
$1 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
0.1
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$-6 Mln
-
ROE
-0.8 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
-3.2
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$-4.3
-
Face value
--
-
Shares outstanding
2,906,930
10 Years Aggregate
CFO
$-72.92 Mln
EBITDA
$-92.66 Mln
Net Profit
$-93.84 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
CohBar (CWBR)
| -24.1 | -24.1 | -22.0 | -45.3 | -64.8 | -65.0 | -- |
|
BSE Sensex*
| -10.9 | -4.9 | -8.9 | -7.6 | 6.9 | 8.3 | 11.5 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|---|---|---|---|---|---|---|---|
|
CohBar (CWBR)
| -27.0 | -56.3 | -83.9 | -73.9 | -16.3 | -48.6 | -37.3 |
|
S&P Small-Cap 600
| 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 | -9.7 |
|
BSE Sensex
| 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 | 5.9 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Shareholding Pattern
View DetailsAbout CohBar (CWBR)
CohBar, Inc., a clinical stage biotechnology company, develops mitochondria and peptides based therapeutics for the treatment of chronic and age-related diseases. It develops CB4211, a therapeutic that is in Phase 1a/1b clinical trial for the... treatment of nonalcoholic steatohepatitis and obesity; and CB5138 Analogs, which is in preclinical study to treat idiopathic pulmonary fibrosis and other fibrotic diseases. CohBar, Inc. was incorporated in 2007 and is based in Menlo Park, California. Read more
-
Founder & Member of Scientific Advisory Board
Dr. Pinchas Cohen Dean, M.D.
-
Founder & Member of Scientific Advisory Board
Dr. Pinchas Cohen Dean, M.D., Ph.D.
-
Headquarters
Menlo Park, CA
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for CohBar (CWBR)
What is the current share price of CohBar Inc (CWBR) Today?
The share price of CohBar Inc (CWBR) is $0.41 (NASDAQ) as of 23-Jan-2025 15:00 EDT. CohBar Inc (CWBR) has given a return of -64.8% in the last 3 years.
What is the current PB & PE ratio of CohBar Inc (CWBR)?
Since, TTM earnings of CohBar Inc (CWBR) is negative, P/E ratio is not available.
The P/B ratio of CohBar Inc (CWBR) is 0.13 times as on 23-Jan-2025, a 97 discount to its peers’ median range of 4.08 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2022
|
-0.41
|
0.32
|
|
2021
|
-0.06
|
0.04
|
|
2020
|
-0.18
|
0.14
|
|
2019
|
-0.17
|
0.28
|
|
2018
|
-0.28
|
0.25
|
What is the 52 Week High and Low of CohBar Inc (CWBR)?
The 52-week high and low of CohBar Inc (CWBR) are Rs -- and Rs -- as of 24-May-2026.
What is the market cap of CohBar Inc (CWBR)?
CohBar Inc (CWBR) has a market capitalisation of $ 1 Mln as on 23-Jan-2025. As per SEBI classification, it is a Small Cap company.
Should I invest in CohBar Inc (CWBR)?
Before investing in CohBar Inc (CWBR), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.